Stock Symbol 01177
About Us
About Sino Biopharm
Management Team
Major Events
R&D
Products
Innovative Products
Oncology
Hepatology
Respiratory
Surgery/Analgesic
Others
News
Sustainability
ESG Strategy and Governance
ESG Policies and Commitments
ESG Dynamics
ESG Reports
Investors
Information Disclosure
Corporate Governance
Presentation
Investor FAQs
Notices
Legel Terms
Our Culture
Human Development
Join Us
CN
EN
Investors
Home
>
Investors
>
Information Disclosure
Information Disclosure
Corporate Governance
Presentation
Investor FAQs
Notices
Information Disclosure
2012 Interim Report
2012.09.17
2011 Annual Report
2012.04.24
Interim Report 2011
2011.09.19
Annual Report 2010
2011.04.21
Interim Report 2010
2010.09.20
Annual Report 2009(Revised)
2010.05.18
Annual Report 2009
2010.04.23
Interim Report 2009
2009.09.24
first page
previous page
59
60
61
62
63
64
65
66
last page
next page
Stock Symbol 01177
Stock Symbol 01177